Market closed
Access this stock data via API
Subscribe
BioInvent International AB
0
0
0%

Financials

Income statement

Fiscal date 2024 2023 2022 2021
Total reported revenue 44.7M 71.5M 326.1M 19.4M
Cost of revenue
Gross profit
Operating expense
Research & development 457.7M 390.4M 325.9M 258.3M
Selling general and admin 58.3M 51.6M 50.8M 39.4M
Other operating expenses -290K
Operating income -471.2M -370.6M -50.5M -278.2M
Non operating interest income
Income 42.1M 40.6M 9.1M 264K
Expense 555K 638K 650K 517K
Other income expense
Pretax income -429.2M -330.1M -42.5M -278.4M
Tax provision 135K 204K 0 0
Net income -429.4M -330.3M -42.5M -278.4M
Basic EPS -6.5 -5.0 -0.7 -5.1
Diluted EPS -6.5 -5.0 -0.7 -5.1
Basic average shares 65.8M 65.8M 61.5M 54.2M
Diluted average shares 65.8M 65.8M 61.5M 54.2M
EBITDA -417.4M -312.7M -27.1M -263.3M
Net income from continuing op. -471.5M -369.9M -50.9M -278.4M
Minority interests
Preferred stock dividends 0 0 0 0
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 1 hour 14 minutes

07:45
00:00
09:00
17:30
23:59

Trading Hours (Monday - Friday):

Main market
09:00 - 17:30
All times are displayed in the Europe/Stockholm timezone (CET, UTC+01:00).